
Habeeba Pharmaceuticals Private Limited
About Habeeba Pharmaceuticals Private Limited
Data last updated:
Habeeba Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 21 December 2016.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2016PTC167617. Its GSTIN is 27AAECH0379N1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammad Shamshad Thakur and Mohammad Aslam Mohammad Dawood Sarwar.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at S. No. 657/8/2 Near Shelke Wasti Bibwewadi, Pune, Maharashtra, India – 411037.
As per the financials filed for FY 2021, the company reported a revenue of ₹18.08 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2 Lakh (net margin 11%) and EBITDA of ₹2 Lakh (EBITDA margin 11%).
Company details
Contact details
Habeeba Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS. No. 657/8/2 Near Shelke Wasti Bibwewadi, Pune, Maharashtra, India – 411037
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Habeeba Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Habeeba Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Habeeba Pharmaceuticals Private Limited, buy the company report.
Financials of Habeeba Pharmaceuticals Private Limited
FY 2021 filings availableHabeeba Pharmaceuticals Private Limited reported revenue of ₹18.08 Lakh (up 170% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 170% in the latest year. EBITDA rose 262% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 11% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Habeeba Pharmaceuticals Private Limited, buy the company report.
Board of directors of Habeeba Pharmaceuticals Private Limited
Habeeba Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Shamshad Thakur | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
| Mohammad Aslam Mohammad Dawood Sarwar | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
| Akram | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
| Sufyan Ahmed Mohammed Ibrahim Ghawte | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Habeeba Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saudharam Pharmaceuticals Private Limited | ₹18.16 Lakh (FY 2024) | -15.0% | Agra, Uttar Pradesh, India | |||
| Adish Pharmaceuticals Private Limited | ₹18.14 Lakh (FY 2024) | 37.0% | Palghar, Maharashtra, India | |||
| Habeeba Pharmaceuticals Private Limitedthis company | ₹18.08 Lakh (FY 2021) | ₹2 Lakh | 11% | 170.0% | Pune, Maharashtra, India | |
| Synthokind Pharmaceuticals Private Limited | ₹18.04 Lakh (FY 2025) | 0.0% | Delhi, India | |||
| Cinala Herbal Private Limited | ₹18.04 Lakh (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Risingsol Pharmaceuticals Private Limited | ₹18.01 Lakh (FY 2024) | Bettiah, Bihar, India |
To see the full peer comparison of Habeeba Pharmaceuticals Private Limited, buy the company report.
Auditor
Habeeba Pharmaceuticals Private Limited is audited by M K PARYANI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M K PARYANI & CO | FY 2019 |
Shareholding
The shareholding of Habeeba Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Habeeba Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Habeeba Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Habeeba Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Habeeba Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECH0379N1Z6 | Maharashtra | Active | 24 Nov 2017 |
To see the full GST registrations and return filing status of Habeeba Pharmaceuticals Private Limited, buy the company report.
Recent activity
Habeeba Pharmaceuticals Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Akram was appointed as Director on 21 Dec 2016.
Frequently asked questions
Habeeba Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Habeeba Pharmaceuticals is a company pending strike off, currently registered as a private limited company based in Pune, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 21 December 2016 and is registered under CIN U74999PN2016PTC167617. The company may be struck off soon - caution is advised.
The compliance status of Habeeba Pharmaceuticals is compliant as of 04 July 2026.
Habeeba Pharmaceuticals has 4 current directors:
- Mohammad Shamshad Thakur - Director
- Mohammad Aslam Mohammad Dawood Sarwar - Director
- Akram - Director
- Sufyan Ahmed Mohammed Ibrahim Ghawte - Director
The CIN (Corporate Identification Number) of Habeeba Pharmaceuticals is U74999PN2016PTC167617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Habeeba Pharmaceuticals was incorporated on 21 December 2016. It is registered with the Registrar of Companies, Pune.
The registered office of Habeeba Pharmaceuticals is at S. No. 65782 Near Shelke Wasti Bibwewadi, Pune, Maharashtra, India – 411037.
The latest financial statements of Habeeba Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Habeeba Pharmaceuticals is 27AAECH0379N1Z6, registered in Maharashtra.
Habeeba Pharmaceuticals operates in the healthcare industry, in the ayurvedic products and services segment.
The peers of Habeeba Pharmaceuticals by revenue are Saudharam Pharmaceuticals Private Limited, Adish Pharmaceuticals Private Limited, Synthokind Pharmaceuticals Private Limited, Cinala Herbal Private Limited, Risingsol Pharmaceuticals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading).

